Aurora Cannabis is one of the largest cannabis companies in the world. It's traded on the Canadian Securities Exchange (CSE) under the ticker symbol ACB.
Aurora Cannabis was founded in 2013 by Steve Dobler, Terry Booth, and other investors. The company's name is inspired by the aurora borealis, also known as the northern lights.
Aurora Cannabis has operations in Canada, the European Union, and Latin America. It has a presence in over 25 countries worldwide.
Aurora Cannabis has a market capitalization of over $10 billion.
On a similar theme: S a Spurs News
Financial Highlights
Aurora Cannabis has a quick ratio of 1.15, indicating a strong ability to pay off its short-term debts.
The company's current ratio is 3.83, which is higher than its peers AYR.A and WEED. This suggests that Aurora Cannabis has a healthy level of liquidity.
Aurora Cannabis' interest coverage ratio is -4.12, which is lower than its peers. This indicates that the company may struggle to meet its interest payments.
Additional reading: Muni Bond Interest Rates
Here's a comparison of the valuation metrics for Aurora Cannabis and its peers:
Aurora Cannabis' market capitalization is 319.98M, while its enterprise value is 292.35M. The company's price-to-sales ratio is 1.24, and its price-to-book ratio is 0.81.
The company's revenue is estimated to grow from 344 CAD in 2025 to 533 CAD in 2029. The average earnings estimate for 2025 is 0.119 CAD, with 6 analysts providing estimates. The average revenue estimate for 2025 is 91 CAD, with 6 analysts providing estimates.
Consider reading: Dow Jones Industrial Average Dividend Yield
Stock Performance
Aurora Cannabis stock has seen significant fluctuations in its performance over the years.
In 2019, the company's stock price rose by over 100% due to its rapid expansion and growing market share.
The stock's market capitalization reached a high of $13.4 billion, making it one of the largest cannabis companies in the world.
However, the stock's performance was impacted by the COVID-19 pandemic, which led to a decline in its stock price.
In 2020, the company's revenue declined by 15% due to the pandemic's effects on the global economy.
Despite this decline, Aurora Cannabis has continued to invest in research and development, expanding its product offerings and improving its operational efficiency.
The company's stock price has shown signs of recovery, with a 20% increase in 2021.
Aurora Cannabis' commitment to innovation and its ability to adapt to changing market conditions have helped it maintain a strong market presence.
The company's stock performance is closely tied to the overall cannabis market, which has experienced significant growth in recent years.
Aurora Cannabis' market share has increased as the company has expanded its operations and product offerings.
Financial Documents
Aurora Cannabis has a financial strength that's worth examining. The company's Quick Ratio is 1.15, which is higher than its peers AYR.A and WEED.
The Current Ratio for Aurora Cannabis is 3.83, indicating a strong ability to pay off short-term debts. In contrast, AYR.A has a Current Ratio of 1.59.
A different take: Formula 1 Ubs
Aurora Cannabis' Interest Coverage is -4.12, which is lower than its peers. This suggests that the company may struggle to pay interest on its debts.
Here's a summary of Aurora Cannabis' financial metrics:
Aurora Cannabis' financial documents are publicly available and provide valuable insights into the company's performance. The company's past earnings reports have shown a mix of positive and negative results.
Company Information
Aurora Cannabis Inc. is a Canadian company founded in 2013 and headquartered in Edmonton, Canada.
The company operates in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
It engages in the propagation of vegetables and floral plants, offering a diverse range of products, including pharmaceutical-grade cannabis, medical and consumer cannabis, and dried and fresh cannabis.
Aurora Cannabis Inc. has a strong brand portfolio, including San Rafael '71, Greybeard, Drift, and Daily Special, among others.
The company's international brands include Pedanios, Bidiol, IndiMed, and CraftPlant.
Aurora Cannabis Inc. operates through two segments: Canadian Cannabis and Plant Propagation.
Explore further: Bmo Stock Quote Canada
Research Reports: Acb
Aurora Cannabis is a Canadian company that cultivates and sells medicinal and recreational cannabis through a portfolio of brands.
Their portfolio includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard.
These brands are primarily sold in Canada, but the company has expanded internationally through medical cannabis exporting agreements.
Aurora Cannabis has a rating from Morningstar, which was last updated 10 months ago.
The company's international expansion has allowed them to reach new markets and increase their customer base.
Here are the brands owned by Aurora Cannabis:
- Drift
- San Rafael '71
- Daily Special
- Whistler
- Being
- Greybeard
Frequently Asked Questions
Is Aurora stock a buy or sell?
Aurora stock holds a short-term buy signal, but a long-term sell signal, indicating mixed market sentiment. Investors may want to consider this conflicting signal before making a decision.
Featured Images: pexels.com
